富信科技(688662.SH):上半年淨利潤2226.07萬元,同比扭虧為盈
格隆匯8月22日丨富信科技(688662.SH)公佈2024年半年度報吿,報吿期內,公司實現營業收入2.52億元,同比增長20.32%;歸屬於上市公司股東的淨利潤2226.07萬元,同比扭虧為盈;歸屬於上市公司股東的扣除非經常性損益的淨利潤2154.36萬元,基本每股收益0.26元。
歸屬於上市公司股東的淨利潤、歸屬於上市公司股東的扣除非經常性損益的淨利潤較去年同期上升,實現扭虧為盈,主要系去年同期因計提 Sleepme
Inc.大額應收壞賬而出現虧損,該應收壞賬已於 2023 年度進行核銷,不對 2024 年的淨利潤產生影響,且公司 2024
年半年度銷售規模上升推動淨利潤增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.